lynda

2016 Peritoneal Cancer Market H1 Therapeutics Development Research

Press Release   •   May 05, 2016 10:01 EDT

In-detail Table of Contents of Peritoneal Cancer Pipeline Market

Companies Involved in Therapeutics Development AbbVie Inc., Acetylon Pharmaceuticals, Inc., Adaptimmune Therapeutics Plc, Aduro BioTech, Inc., Advanced Accelerator Applications SA, Advenchen Laboratories, LLC, Amgen Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., AstraZeneca Plc, Atara Biotherapeutics, Inc., AVEO Pharmaceuticals, Inc., Bayer AG, Boehringer Ingelheim GmbH, Boston Biomedical, Inc., Caladrius Biosciences, Inc., Celldex Therapeutics, Inc., Celsion Corporation, CerRx, Inc., Cerulean Pharma, Inc., Clovis Oncology, Inc., Corcept Therapeutics Incorporated, Critical Outcome Technologies Inc., CritiTech, Inc., CTI BioPharma Corp., Dr. Reddy's Laboratories Limited, EirGenix Inc., Eli Lilly and Company, Epirus Biopharmaceuticals, Inc., Exelixis, Inc., F. Hoffmann-La Roche Ltd., Galena Biopharma, Inc., Ganymed Pharmaceuticals AG, Genelux Corporation, Genentech, Inc., Genor BioPharma Co., Ltd., Glycotope GmbH, Gradalis Inc., Hemispherx Biopharma, Inc., ImmunoGen, Inc., Immunovaccine, Inc., Incyte Corporation, Innate Pharma S.A., Johnson & Johnson, Juno Therapeutics Inc., Kyowa Hakko Kirin Co., Ltd., Lee's Pharmaceutical Holdings Limited, Mabion SA, MabVax Therapeutics Holdings, Inc., MedImmune, LLC, Medivation, Inc., Merck & Co., Inc., Millennium Pharmaceuticals, Inc., MolMed S.p.A., Mycenax Biotech Inc., Novartis AG, Oasmia Pharmaceutical AB, OBI Pharma, Inc., Oncobiologics, Inc., Oncolix, Inc., Oncolytics Biotech Inc., OncoMed Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., Oxford BioMedica Plc, OXiGENE, Inc., Pharma Mar, S.A., Pharmacyclics, Inc., PsiOxus Therapeutics Limited, Quest PharmaTech Inc., Sanofi Pasteur SA, Shenzen SiBiono GeneTech Co., Ltd., Sotio a.s., Synta Pharmaceuticals Corp., TapImmune Inc., Tesaro, Inc., TetraLogic Pharmaceuticals, Tyrogenex, Inc., Vascular Biogenics Ltd. and VentiRx Pharmaceuticals, Inc.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=539816 .

Research provides:

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Peritoneal Cancer
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Peritoneal Cancer pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Complete research report at http://www.rnrmarketresearch.com/peritoneal-cancer-pipeline-review-h1-2016-market-report.html .

List of figures:

  • Number of Products under Development for Peritoneal Cancer, H1 2016
  • Number of Products under Development for Peritoneal Cancer - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Late Stage Development, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Top 10 Targets, H1 2016
  • Number of Products by Stage and Top 10 Targets, H1 2016
  • Number of Products by Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Top 10 Routes of Administration, H1 2016
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2016
  • Number of Products by Top 10 Molecule Types, H1 2016
  • Number of Products by Stage and Top 10 Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.